Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.31 |
| ▸ | PNMT | P11086 | 3/20 | 0.31 |
| ▸ | AADAT | Q8N5Z0 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31346112 | 0.83 | SLC22A12 (0.34) | CASP3CASP7CASP8PNMTAADAT | |
| SCHEMBL31346114 | 0.80 | KIF11 (0.36) | KIF11PNMTHTR2AHTR2CHTR2B | |
| SCHEMBL31345998 | 0.80 | PNMT (0.32) | PNMT | |
| SCHEMBL31345995 | 0.77 | CYP19A1 (0.45) | KIF11HTR2C | |
| SCHEMBL31346117 | 0.77 | CYP19A1 (0.45) | KIF11HTR2C | |
| SCHEMBL31346129 | 0.76 | TRPM5 (0.35) | KIF11PNMTEGLN1 | |
| SCHEMBL31346029 | 0.75 | CYP11B1 (0.40) | KIF11EGLN1 | |
| SCHEMBL31346109 | 0.75 | ELANE (0.34) | KIF11EGLN1 | |
| SCHEMBL31346147 | 0.75 | MRGPRX4 (0.36) | KIF11CASP3CASP7CASP8PNMT | |
| SCHEMBL31346005 | 0.75 | ELANE (0.34) | KIF11EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712967-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | Enveda Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024239000-A2 | G-PROTEIN COUPLED RECEPTOR ANTAGONIST | ENVEDA THERAPEUTICS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |